Status:
COMPLETED
Using Pharmacogenetics to Improve Treatment in Early-onset Diabetes
Lead Sponsor:
University of Exeter
Collaborating Sponsors:
University of Dundee
Wellcome Trust
Conditions:
Diabetes
Eligibility:
All Genders
Up to 50 years
Brief Summary
Monogenic diabetes is an unusual form of diabetes. It usually presents in patients under the age of 30, so is often misdiagnosed as Type 1 diabetes which is more common. Patients with monogenic diabet...
Detailed Description
Aim:The aim of this project is to identify a patient pathway which ensures that patients with young-onset diabetes (diagnosed \<30 years) have a systematic series of investigations which allow for app...
Eligibility Criteria
Inclusion
- clinical diagnosis of diabetes
- diagnosed under 30 years of ages
- current age less than 50 years
- willing and able to provide informed consent.
Exclusion
- age over 50 years
- age at diagnosis over 30 years
- adult with incapacity to consent
- child with incapacity to assent
Key Trial Info
Start Date :
December 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2013
Estimated Enrollment :
1916 Patients enrolled
Trial Details
Trial ID
NCT01238380
Start Date
December 1 2010
End Date
September 1 2013
Last Update
March 19 2019
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Peninsula NIHR Clinical Research Facility, Peninsula Medical School, Barrack Rd,
Exeter, Devon, United Kingdom, EX2 5DW
2
Peninsula College of Medicine & Dentistry, University of Plymouth, John Bull Building, Tamar Science Park,
Plymouth, Devon, United Kingdom, PL6 8BU
3
Biomedical Research Institute, University of Dundee,
Dundee, United Kingdom, DD1 9SY